Targeted Therapy for Kaposi Sarcoma
Current Status and Challenges Associated with Targeting mTOR for Cancer Therapy
Strategies to Extend Plasma Half-Lives of Recombinant Antibodies
Biologic Therapy for Rheumatoid Arthritis
Golimumab